# Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)

> **NCT00993525** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 22 (estimated)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Intravitreal injection of ranibizumab

## Key facts

- **NCT ID:** NCT00993525
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2009-10-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993525, "Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00993525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*